Vanguard Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7M | Sell |
3,020,100
-19,631
| -0.6% | -$148K | ﹤0.01% | 2500 |
|
|
2025
Q1 | $23M | Buy |
3,039,731
+103,504
| +4% | +$784K | ﹤0.01% | 2449 |
|
|
2024
Q4 | $35.8M | Sell |
2,936,227
-62,487
| -2% | -$761K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $50.2M | Buy |
2,998,714
+127,339
| +4% | +$2.13M | ﹤0.01% | 2178 |
|
|
2024
Q2 | $50.1M | Buy |
2,871,375
+1,097,030
| +62% | +$19.1M | ﹤0.01% | 2141 |
|
|
2024
Q1 | $30.2M | Buy |
1,774,345
+2,902
| +0.2% | +$49.5K | ﹤0.01% | 2392 |
|
|
2023
Q4 | $18.1M | Buy |
1,771,443
+82,910
| +5% | +$845K | ﹤0.01% | 2643 |
|
|
2023
Q3 | $15.3M | Sell |
1,688,533
-338,873
| -17% | -$3.07M | ﹤0.01% | 2664 |
|
|
2023
Q2 | $21.8M | Sell |
2,027,406
-527,582
| -21% | -$5.68M | ﹤0.01% | 2552 |
|
|
2023
Q1 | $26.1M | Sell |
2,554,988
-257,977
| -9% | -$2.64M | ﹤0.01% | 2473 |
|
|
2022
Q4 | $29.7M | Buy |
2,812,965
+47,960
| +2% | +$506K | ﹤0.01% | 2439 |
|
|
2022
Q3 | $35.4M | Buy |
2,765,005
+19,486
| +0.7% | +$250K | ﹤0.01% | 2350 |
|
|
2022
Q2 | $35.2M | Buy |
2,745,519
+393,394
| +17% | +$5.04M | ﹤0.01% | 2361 |
|
|
2022
Q1 | $24.6M | Sell |
2,352,125
-14,683
| -0.6% | -$154K | ﹤0.01% | 2656 |
|
|
2021
Q4 | $36.5M | Buy |
2,366,808
+85,357
| +4% | +$1.32M | ﹤0.01% | 2524 |
|
|
2021
Q3 | $51.5M | Buy |
2,281,451
+1,125,686
| +97% | +$25.4M | ﹤0.01% | 2347 |
|
|
2021
Q2 | $29.8M | Buy |
1,155,765
+4,478
| +0.4% | +$115K | ﹤0.01% | 2635 |
|
|
2021
Q1 | $48M | Buy |
+1,151,287
| New | +$48M | ﹤0.01% | 2339 |
|